NTRA

#434
Natera, Inc. - Common Stock
220.8 7 USD
+3.14%
Setor: Cuidados de saúde
Base: USD
Moeda do lucro: USD
Faixa diária
211.40
221.50
Faixa anual
131.81
256.27
Mudança diária
+3.14%
Mudança mensal
+11.90%
Mudança em 6 meses
-7.44%
Mudança anual
+40.23%
Fechamento anterior
214.1 4
Open
214.9 7
Mínimo
211.4 0
High
221.5 0
Volume
638
Abrir gráfico completo Full chart

Financials

Visão geral Relatórios Estatísticas
Trimestral Ano
  • Market Capitalization 31.63 B
  • Employee 6 140
  • Founded 2004
  • CEO Steven Chapman
  • Website www.natera.com
  • Headquarter Delaware, United States
  • FIGI BBG001J1BQ86
  • Industry Diagnósticos e pesquisa
Receita total
Lucro líquido
Lucro básico por ação
Dívida total
Fluxo de caixa livre
Caixa e equivalentes de caixa
Índice preço/lucro
-150.72
Índice preço/fluxo de caixa
13.58

Natera, Inc. - Common Stock

Natera, Inc. is a clinical genetic testing company based in Austin, Texas that specializes in non-invasive, cell-free DNA testing technology, with a focus on women's health, cancer, and organ health. Natera's proprietary technology combines novel molecular biology techniques with a suite of bioinformatics software that allows detection down to a single molecule in a tube of blood. Natera operates CAP-accredited laboratories certified under the Clinical Laboratory Improvement Amendments in San Carlos, California and Austin, Texas.

Notícias